Obesity drugs aren’t always forever. What happens when you quit?

McKenzie Prillaman

Nature, 2024, vol. 628, issue 8008, 488-490

Abstract: Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off them.

Keywords: Obesity; Metabolism; Drug discovery (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-01091-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:628:y:2024:i:8008:d:10.1038_d41586-024-01091-8

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-01091-8

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().